This study demonstrates that hepatic Ago2-mediated RNA silencing regulates energy expenditure during the course of obesity and its inactivation protects from obesity-associated glucose intolerance and hepatic steatosis in mice. This evidence concerns the gene AGO2 and obesity due to melanocortin 4 receptor deficiency.